J. van Doorn

发表

Clinical and biochemical characteristics of a male patient with a novel homozygous STAT5b mutation.

R. Janssen, J. Romijn, S. White, 2006, The Journal of clinical endocrinology and metabolism.

IGF-1 Levels, Complex Formation, and IGF Bioactivity in Growth Hormone-Treated Children With Prader-Willi Syndrome.

A. Hokken-Koelega, J. van Doorn, N. Bakker, 2015, The Journal of clinical endocrinology and metabolism.

Insulin-Like Growth Factors and Leucine Kinetics During Exercise Training in Children With Cystic Fibrosis

K. de Meer, R. Berger, V. Gulmans, 2001, Journal of pediatric gastroenterology and nutrition.

Growth hormone secretion and immunological function of a male patient with a homozygous STAT5b mutation.

R. Janssen, J. Romijn, H. V. van Duyvenvoorde, 2007, European journal of endocrinology.

Ternary complex formation and IGFBP-3 proteolytic activity during childhood: age-dependent changes.

A. Hokken-Koelega, J. van Doorn, J. Renes, 2014, The Journal of clinical endocrinology and metabolism.

Biochemical markers of growth hormone (GH) sensitivity in children with idiopathic short stature: individual capacity of IGF‐I generation after high‐dose GH treatment determines the growth response to GH

A. Zwinderman, J. Wit, M. Frölich, 2002, Clinical endocrinology.

Homozygous and heterozygous expression of a novel insulin-like growth factor-I mutation.

Jeroen J. Bax, J. Romijn, S. Mohan, 2005, The Journal of clinical endocrinology and metabolism.

No Effect of Red Clover–Derived Isoflavone Intervention on the Insulin-Like Growth Factor System in Women at Increased Risk of Colorectal Cancer

L. V. van't Veer, D. Voskuil, F. V. van Leeuwen, 2008, Cancer Epidemiology Biomarkers & Prevention.

IGF-Binding Protein-1 Levels Are Related to Insulin-Mediated Glucose Disposal and Are a Potential Serum Marker of Insulin Resistance

M. Zonderland, J. van Doorn, T. V. van Haeften, 2007, Diabetes Care.

The insulin-like growth factor-system in a patient with diffuse large B-cell non-Hodgkin's lymphoma and lactic acidosis

J. van Doorn, E. Maartense, D. Hoogwerf, 2013, Annals of clinical biochemistry.

Insulin‐like growth factors (IGF‐I, free IGF‐I, and IGF‐II) and insulin‐like growth factor binding proteins (IGFBP‐2, IGFBP‐3, IGFBP‐6, and ALS) in blood circulation

A. Juul, J. van Doorn, M. Nicar, 1999, Journal of clinical laboratory analysis.

Insulin‐like growth‐factor‐binding protein 3 is decreased in early‐stage operable pre‐menopausal breast cancer

T. C. Linders, A. Hart, P. V. van Noord, 1995, International journal of cancer.

Serum insulin-like growth factor-binding protein-2 levels and metabolic and cardiovascular risk factors in young adults and children born small for gestational age.

A. Hokken-Koelega, J. van Doorn, R. Leunissen, 2010, The Journal of clinical endocrinology and metabolism.

Insulin-like growth factor-binding protein-1: serum levels, promoter polymorphism, and associations with components of the metabolic syndrome in short subjects born small for gestational age.

C. Deal, A. Hokken-Koelega, J. van Doorn, 2009, The Journal of clinical endocrinology and metabolism.

Dehydroepiandrosterone Sulfate Treatment for Atrichia pubis

J. Wit, J. van Doorn, W. Oostdijk, 2001, Hormone Research in Paediatrics.

Insulin-like growth factors and insulin-like growth factor-binding proteins in relation to disease status and incidence of hypoglycaemia in patients with a gastrointestinal stromal tumour.

S. de Jong, P. Jager, B. Rikhof, 2009, Annals of oncology : official journal of the European Society for Medical Oncology.

Effects of Lycopene on the Insulin-Like Growth Factor (IGF) System in Premenopausal Breast Cancer Survivors and Women at High Familial Breast Cancer Risk

L. V. van't Veer, D. Voskuil, S. Verhoef, 2008, Nutrition and cancer.

Isolated isoflavones do not affect the circulating insulin-like growth factor system in men at increased colorectal cancer risk.

L. V. van't Veer, D. Voskuil, F. V. van Leeuwen, 2007, The Journal of nutrition.

Lycopene supplementation elevates circulating insulin-like growth factor binding protein-1 and -2 concentrations in persons at greater risk of colorectal cancer.

L. V. van't Veer, D. Voskuil, F. V. van Leeuwen, 2007, The American journal of clinical nutrition.

Non-islet cell tumour-induced hypoglycaemia: a review of the literature including two new cases.

B. Rikhof, J. D. de Groot, W. T. van der Graaf, 2007, Endocrine-related cancer.

Differential patterns of insulin‐like growth factor‐I and ‐II mRNA expression in medulloblastoma

P. Wesseling, J. van Doorn, R. Reddingius, 2004, Neuropathology and applied neurobiology.

Acid-Labile Subunit Levels and the Association with Response to Growth Hormone Treatment in Short Children Born Small for Gestational Age

A. Hokken-Koelega, M. D. de Ridder, J. van Doorn, 2014, Hormone Research in Paediatrics.

Efficacy of needle-free administration of recombinant human growth hormone in adults with growth hormone deficiency.

J. Romijn, F. Roelfsema, H. Koppeschaar, 2006, British journal of clinical pharmacology.

Insulin‐like growth factor‐II and bioactive proteins containing a part of the E‐domain of pro‐insulin‐like growth factor‐II

J. van Doorn, 2020, BioFactors.

Antibodies directed against the E region of pro-insulin-like growth factor-II used to evaluate non-islet cell tumor-induced hypoglycemia.

J. van Doorn, K. Hoekman, C. Hoogerbrugge, 2002, Clinical chemistry.

Hypoglycaemia associated with the production of insulin‐like growth factor II and insulin‐like growth factor binding protein 6 by a haemangiopericytoma

J. Maassen, H. Pinedo, J. van Doorn, 1999, Clinical endocrinology.

Acute stress response in children with meningococcal sepsis: important differences in the growth hormone/insulin-like growth factor I axis between nonsurvivors and survivors.

W. Hop, J. Hazelzet, J. van Doorn, 2002, The Journal of clinical endocrinology and metabolism.

Short stature associated with a novel heterozygous mutation in the insulin-like growth factor 1 gene.

J. Wade, C. Ruivenkamp, H. V. van Duyvenvoorde, 2010, The Journal of clinical endocrinology and metabolism.

Free/dissociable insulin-like growth factor (IGF)-I, not total IGF-I, correlates with growth response during growth hormone treatment in children born small for gestational age.

A. Hokken-Koelega, J. van Doorn, E. Bannink, 2007, The Journal of clinical endocrinology and metabolism.

Mutations in the NSD1 gene in patients with Sotos syndrome associate with endocrine and paracrine alterations in the IGF system.

H. V. van Duyvenvoorde, J. Wit, M. Karperien, 2004, European journal of endocrinology.

Plasma Levels of Insulin-Like Growth Factor (IGF)-I, IGF-II and IGF-Binding Protein-3 in the Evaluation of Childhood Growth Hormone Deficiency

J. Wit, J. van den Brande, J. van Doorn, 1998, Hormone Research in Paediatrics.

Expression of osteotropic growth factors and growth hormone receptor in a canine distraction osteogenesis model

G. Voorhout, J. van Doorn, J. Mol, 2006, Journal of Bone and Mineral Metabolism.

Insulin‐like growth factors (IGF‐I, free IGF‐I, and IGF‐II) and insulin‐like growth factor binding proteins (IGFBP‐2, IGFBP‐3, IGFBP‐6, and ALS) in blood circulation

A. Juul, J. van Doorn, M. Nicar, 1999, Journal of clinical laboratory analysis.

Atypical STAT5B deficiency, severe short stature and mild immunodeficiency associated with a novel homozygous STAT5B Variant

M. Losekoot, J. Wit, V. Hwa, 2022, Molecular and Cellular Endocrinology.

Plasma levels of insulin‐like growth factor binding protein‐4 (IGFBP‐4) under normal and pathological conditions

J. van Doorn, S. van Buul-Offers, A. J. F. H. Cornelissen, 2001, Clinical endocrinology.

Ethinylestradiol and testosterone have divergent effects on circulating IGF system components in adolescents with constitutional tall stature.

L. O. de Beeck, Raoul Rooman, S. Mohan, 2005, European journal of endocrinology.

Free dissociable insulin‐like growth factor I (IGF‐I), total IGF‐I and their binding proteins in girls with Turner syndrome during long‐term growth hormone treatment

T. Stijnen, J. van Doorn, S. Drop, 2006, Clinical endocrinology.

Impaired Body Weight and Tail Length Gain and Altered Bone Quality after Treatment with the Aromatase Inhibitor Exemestane in Male Rats

J. Wit, L. Garcia-Segura, M. Karperien, 2010, Hormone Research in Paediatrics.

Marginal Growth Increase, Altered Bone Quality and Polycystic Ovaries in Female Prepubertal Rats after Treatment with the Aromatase Inhibitor Exemestane

J. Wit, L. Garcia-Segura, M. Karperien, 2010, Hormone Research in Paediatrics.

Longitudinal analysis of ocular disease in children with Mucopolysaccharidosis I after hematopoietic cell transplantation.

J. van Doorn, P. V. van Hasselt, J. Boelens, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Hurdles in treating Hurler disease: potential routes to achieve a "real" cure.

S. Nierkens, J. van Doorn, P. V. van Hasselt, 2020, Blood advances.

Salivary α-Iduronidase Activity as a Potential New Biomarker for the Diagnosis and Monitoring the Effect of Therapy in Mucopolysaccharidosis Type I.

J. van Doorn, P. V. van Hasselt, J. Boelens, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Column chromatographic characterization of complex formation of pro-IGF-II isoforms with acid labile subunit and IGF-binding proteins associated with non-islet cell tumour induced hypoglycaemia.

E. Lentjes, R. Huits, J. van Doorn, 2014, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

'Big'-insulin-like growth factor-II signaling is an autocrine survival pathway in gastrointestinal stromal tumors.

E. Schuuring, S. de Jong, G. Meersma, 2012, The American journal of pathology.

Various components of the insulin‐like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients

M. D. Den Boer, R. Pieters, J. van Doorn, 2008, International journal of cancer.

Non-islet-cell tumor induced hypoglycemia in patients with advanced gastrointestinal stromal tumor possibly worsened by imatinib.

S. Sleijfer, J. Verweij, P. Hamberg, 2006, Journal of Clinical Oncology.

Homozygous and heterozygous expression of a novel mutation of the acid-labile subunit.

M. Kempers, H. V. van Duyvenvoorde, M. Losekoot, 2008, European journal of endocrinology.

Expression of insulin-like growth factor system components in colorectal tissue and its relation with serum IGF levels.

D. Voskuil, J. Wesseling, E. Kampman, 2009, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Catch-up growth and endocrine changes in childhood celiac disease. Endocrine changes during catch-up growth.

J M Wit, J. Wit, R. Houwen, 2002, Hormone research.

Catch-Up Growth and Endocrine Changes in Childhood Celiac Disease

J. Wit, R. Houwen, W. Blum, 2002, Hormone Research in Paediatrics.

Current Insights into the Role of the Growth Hormone-Insulin-Like Growth Factor System in Short Children Born Small for Gestational Age

A. Hokken-Koelega, J. van Doorn, J. Renes, 2019, Hormone Research in Paediatrics.

Plasma Levels of Insulin-Like Binding Protein-2 in Prepubertal Short Children and Its Diagnostic Value in the Evaluation of Growth Hormone Deficiency

J. van Doorn, S. van Buul-Offers, B. Rikken, 2001, Hormone Research in Paediatrics.

Sustained effects of recombinant GH replacement after 7 years of treatment in adults with GH deficiency.

O. Dekkers, J. Romijn, F. Roelfsema, 2006, European journal of endocrinology.

IGF-I, IGF-II, 'free' IGF-I and IGF-binding proteins-2 to -6 during high-dose oestrogen treatment in constitutionally tall girls.

L. O. de Beeck, Raoul Rooman, S. Mohan, 2002, European journal of endocrinology.

The severe short stature in two siblings with a heterozygous IGF1 mutation is not caused by a dominant negative effect of the putative truncated protein.

J. Wade, C. Ruivenkamp, H. V. van Duyvenvoorde, 2011, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Clinical and biochemical characteristics and bone mineral density of homozygous, compound heterozygous and heterozygous carriers of three novel IGFALS mutations.

M. Losekoot, J. Wit, J. van Doorn, 2017, European journal of endocrinology.

Quantitative analysis of the concentrations of IGFs and several IGF-binding proteins in a large fibrous abdominal tumor and the circulation of a patient with hypoglycemia.

R. Dullaart, J. van Doorn, Wouter van de Hoef, 2015, BioFactors.

Genetic Analysis of Short Children with Apparent Growth Hormone Insensitivity

H. Delemarre-van de Waal, C. Ruivenkamp, H. V. van Duyvenvoorde, 2012, Hormone Research in Paediatrics.